FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as ...
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
来自MSN28 分钟
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...